International Valuation Protocol for the EQ-5D-Y-3L.

Ramos-Goni JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N (2020)
PharmacoEconomics.

Zeitschriftenaufsatz | E-Veröff. vor dem Druck | Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor*in
Ramos-Goni, Juan M; Oppe, Mark; Stolk, Elly; Shah, Koonal; Kreimeier, SimoneUniBi; Rivero-Arias, Oliver; Devlin, Nancy
Abstract / Bemerkung
The EQ-5D-Y-3L is a generic, health-related, quality-of-life instrument for use in younger populations. Some methodological studies have explored the valuation of children's EQ-5D-Y-3L health states. There are currently no published value sets available for the EQ-5D-Y-3L that are appropriate for use in a cost-utility analysis. The aim of this article was to describe the development of the valuation protocol for the EQ-5D-Y-3L instrument. There were several research questions that needed to be answered to develop a valuation protocol for EQ-5D-Y-3L health states. Most important of these were: (1) Do we need to obtain separate values for the EQ-5D-Y-3L, or can we use the ones from the EQ-5D-3L? (2) Whose values should we elicit: children or adults? (3) Which valuation methods should be used to obtain values for child's health states that are anchored in Full health=1 and Dead=0? The EuroQol Research Foundation has pursued a research programme to provide insight into these questions. In this article, we summarized the results of the research programme concluding with the description of the features of the EQ-5D-Y-3L valuation protocol. The tasks included in the protocol for valuing EQ-5D-Y-3L health states are discrete choice experiments for obtaining the relative importance of dimensions/levels and composite time-trade-off for anchoring the discrete choice experiment values on 1=Full Health and 0=Dead. This protocol is now available for use by research teams to generate EQ-5D-Y-3L value sets for their countries allowing the implementation of a cost-utility analysis for younger populations.
Erscheinungsjahr
2020
Zeitschriftentitel
PharmacoEconomics
eISSN
1179-2027
Page URI
https://pub.uni-bielefeld.de/record/2942699

Zitieren

Ramos-Goni JM, Oppe M, Stolk E, et al. International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics. 2020.
Ramos-Goni, J. M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O., & Devlin, N. (2020). International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics. doi:10.1007/s40273-020-00909-3
Ramos-Goni, J. M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O., and Devlin, N. (2020). International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics.
Ramos-Goni, J.M., et al., 2020. International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics.
J.M. Ramos-Goni, et al., “International Valuation Protocol for the EQ-5D-Y-3L.”, PharmacoEconomics, 2020.
Ramos-Goni, J.M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O., Devlin, N.: International Valuation Protocol for the EQ-5D-Y-3L. PharmacoEconomics. (2020).
Ramos-Goni, Juan M, Oppe, Mark, Stolk, Elly, Shah, Koonal, Kreimeier, Simone, Rivero-Arias, Oliver, and Devlin, Nancy. “International Valuation Protocol for the EQ-5D-Y-3L.”. PharmacoEconomics (2020).

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 32297224
PubMed | Europe PMC

Suchen in

Google Scholar